Posted by Michael Wonder on 20 Mar 2026
Political influence ‘a serious problem’ for FDA under Trump, former commissioner says
19 March 2026 - Political influence ‘a serious problem’ for FDA under Trump, former commissioner says.
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly.
At least that’s how Robert Califf, former commissioner of the FDA, sees it, he said at STAT’s Breakthrough Summit East on Thursday. New bespoke gene therapies, which may only treat a small number of patients, could hold great promise in the aggregate, he suggested, if the agency can properly assess them.
